These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9595459)

  • 1. Effects of endothelin receptor antagonism and angiotensin-converting enzyme inhibition on cardiac and renal remodeling in the rat.
    Willette RN; Minehart H; Ellison J; Simons T; Short B; Pullen M; Ohlstein EH; Nambi P
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S277-83. PubMed ID: 9595459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
    Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
    Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R; Young SD; Strosberg AM
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition.
    Grimm D; Kromer EP; Böcker W; Bruckschlegel G; Holmer SR; Riegger GA; Schunkert H
    J Hypertens; 1998 Sep; 16(9):1345-55. PubMed ID: 9746122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury.
    Rana I; Velkoska E; Patel SK; Burrell LM; Charchar FJ
    Am J Physiol Renal Physiol; 2015 Dec; 309(11):F943-54. PubMed ID: 26400542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
    Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
    J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
    Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G
    Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic immunosuppression fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats.
    Jeron A; Straub RH; Kaiser T; Riegger GA; Muders F
    Immunobiology; 2002 Mar; 205(1):51-60. PubMed ID: 11999344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats.
    Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E
    Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique endothelin receptor binding in kidneys of ETB receptor deficient rats.
    Taylor TA; Gariepy CE; Pollock DM; Pollock JS
    Am J Physiol Regul Integr Comp Physiol; 2003 Mar; 284(3):R674-81. PubMed ID: 12611392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function.
    Forbes JM; Hewitson TD; Becker GJ; Jones CL
    Kidney Int; 2001 Apr; 59(4):1333-41. PubMed ID: 11260394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin ETA receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats.
    De Smet HR; Menadue MF; Oliver JR; Phillips PA
    Clin Exp Pharmacol Physiol; 2003 Apr; 30(4):278-83. PubMed ID: 12680847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
    Linz W; Schölkens BA; Ganten D
    Clin Exp Hypertens A; 1989; 11(7):1325-50. PubMed ID: 2530011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin-converting enzyme reduces susceptibility of hypertrophied rat myocardium to ventricular fibrillation.
    Shimada Y; Gunasegaram S; Yokoyama H; Avkiran M
    Circ J; 2002 Nov; 66(11):1045-53. PubMed ID: 12419938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction.
    Moridaira K; Morrissey J; Fitzgerald M; Guo G; McCracken R; Tolley T; Klahr S
    Am J Physiol Renal Physiol; 2003 Jan; 284(1):F209-17. PubMed ID: 12473537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
    Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
    Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.